Literature DB >> 6447533

Comparison of haemodynamic effects of anaesthetic doses of alphaprodine and sulfentanil in the dog.

P Reddy, W S Liu, D Port, S Gillmor, T H Stanley.   

Abstract

The haemodynamic effects of equi-anaesthetic doses of alphaprodine and sulfentanil were evaluated in mongrel dogs ventilated mechanically. The effects of the addition of atropine were assessed for each drug, as were the effects of breathing nitrous oxide 60 per cent with oxygen and nitrogen 60 per cent with oxygen and the administration of naloxone. The results of this study demonstrate that anaesthetic doses of sulfentanil produce little change in cardiovascular dynamics in atropinized dogs and only small changes in dogs without atropine premedication, irrespective of the infusion rate. In contrast alphaprodine causes a significant cardiovascular depression irrespective of the presence or absence of atropine premedication. Naloxone reversed the anaesthetic effects in all dogs anaesthetized with alphaprodine but did not reverse the anaesthetic state in any dog given sulfentanil. Our data suggest that sulfentanil deserves evaluation as a narcotic anaesthetic in man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6447533     DOI: 10.1007/bf03007455

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  15 in total

1.  Effects of anesthetic doses of morphine on renal function in the dog.

Authors:  A V Bidwai; T H Stanley; H A Bloomer; R A Blatnick
Journal:  Anesth Analg       Date:  1975 May-Jun       Impact factor: 5.108

2.  The results of nisentil in 1,000 obstetrical cases.

Authors:  W M KANE
Journal:  Am J Obstet Gynecol       Date:  1953-05       Impact factor: 8.661

3.  The effects of high-dose morphine on fluid and blood requirements in open-heart operations.

Authors:  T H Stanley; N H Gray; W Stanford; R Armstrong
Journal:  Anesthesiology       Date:  1973-06       Impact factor: 7.892

4.  Morphine "anesthesia"--a perspective.

Authors:  E Lowenstein
Journal:  Anesthesiology       Date:  1971-12       Impact factor: 7.892

5.  Cardiovascular response to large doses of intravenous morphine in man.

Authors:  E Lowenstein; P Hallowell; F H Levine; W M Daggett; W G Austen; M B Laver
Journal:  N Engl J Med       Date:  1969-12-18       Impact factor: 91.245

6.  Anesthetic requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man.

Authors:  T H Stanley; L R Webster
Journal:  Anesth Analg       Date:  1978 Jul-Aug       Impact factor: 5.108

7.  Cardiovascular effects of nitrous oxide during meperidine infusion in the dog.

Authors:  T H Stanley; A V Bidwai; J K Lunn; M R Hodges
Journal:  Anesth Analg       Date:  1977 Nov-Dec       Impact factor: 5.108

8.  Hemodynamic responses to low doses of naloxone after narcotic-nitrous oxide anesthesia.

Authors:  J M Desmonts; G Bohm; E Couderc
Journal:  Anesthesiology       Date:  1978-07       Impact factor: 7.892

9.  Fentanyl-oxygen anaesthesia for coronary artery surgery: cardiovascular and antidiuretic hormone responses.

Authors:  T H Stanley; D M Philbin; C H Coggins
Journal:  Can Anaesth Soc J       Date:  1979-05

10.  Urinary excretion of morphine during and after valvular and coronary-artery surgery.

Authors:  T H Stanley; G D Lathrop
Journal:  Anesthesiology       Date:  1977-03       Impact factor: 7.892

View more
  3 in total

Review 1.  Sufentanil. A review of its pharmacological properties and therapeutic use.

Authors:  J P Monk; R Beresford; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

2.  The cardiovascular sparing effect of fentanyl and atropine, administered to enflurane anesthetized dogs.

Authors:  J E Ilkiw; P J Pascoe; S C Haskins; J D Patz; R Jaffe
Journal:  Can J Vet Res       Date:  1994-10       Impact factor: 1.310

Review 3.  Clinical pharmacokinetics of the newer intravenous anaesthetic agents.

Authors:  P J Davis; D R Cook
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.